0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
The Serum Institute of India (SII) and the Department of Biotechnology (DBT) are set to launch India's first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against Cervical Cancer.
Share this article
If you liked this article share it with your friends.they will thank you later